Delivery Order SPE2DB20D9127-SPE2DB25FPQP0
Award Date
5/13/25
Potential Completion Date
6/4/25
Potential Value
$30K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $29,616.86 firm fixed-price delivery order is for the supply of 3,750 units of the 5 ml vial drug ASPARLAS, with a completion date of February 27, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award, with the ID SPE2DB20D9127|SPE2DB24FPPR7, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $55,229.58 firm fixed-price delivery order is for the provision of 3,750 units of the 5 mL vial of the drug ASPARLAS. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award, valued at $55,229.58, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order, is for the supply of 3,750 units of a 5 ml vial of the medication ASPARLAS. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $118,467.44 firm fixed-price delivery order is for the supply of 3,750 units of the 5 ml vial of the pharmaceutical product ASPARLAS, with a period of performance through February 3, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award, valued at $118,467.44, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 3,750 units of the drug ASPARLAS in 5 mL vials. The contract has an ultimate completion date of April 1, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,614.78 fixed-price contract is for the delivery of 3,750 units of the drug Asparlas (5 mL vials) with a performance period through May 13, 2024. The award is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA, which allows the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $29,616.86 contract is for the delivery of 3,750 units of the drug ASPARLAS (5 mL vial) with a period of performance through April 18, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 3,750 units of the pharmaceutical product ASPARLAS in 5 mL vials. The contract has a potential value of $55,229.58 and a completion date of March 13, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA valued at up to $4,999,999, which enables the agency to order a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $138,073.90, is for the delivery of 3,750 units of the pharmaceutical product ASPARLAS in 5 ML vials. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. This IDC,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a major supply chain management agency within the Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $55,229.58, is a firm fixed-price delivery order under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA. This IDC, part of the DLA's SPE2DB program, allows the...